Abstract

Economic concerns are increasingly important in health system design, provider payment, and research funding decisions. Cost estimates are needed to provide insight into where the potential opportunities for cost-savings lie and to lay the groundwork for research to determine how to treat the disorder more effectively. The methods used by economists to estimate the direct and indirect costs of epilepsy are reviewed and results from studies in different countries are discussed. General patterns across patients with different types of conditions are reported. Gaps in the literature are identified and future research needs are assessed.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call